GPCR/G protein
All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
- B2167 MRS 2578Summary: P2Y6 receptor antagonist,potent and selective
- B2265 BRL-15572Summary: 5-HT1D receptor antagonist
- B1324 CGS 21680 HClSummary: A2 adenosine receptor agonist
- B2245 BRL-54443Summary: 5-HT1E/1F receptor agonist,potent and selective
- B1426 Org 27569Target: CB1 ReceptorsSummary: Cannabinoid CB1 receptor allosteric modulator
- B1792 Montelukast SodiumSummary: Leukotriene receptor antagonist
- B1896 BetamethasoneSummary: Glucocorticoid receptor agonist
- B1248 Beclomethasone dipropionateSummary: Corticosteroid used for asthma and rhinitis
- B1900 BudesonideSummary: Anti-inflammatory corticosteroid
- B1511 Mifepristone3 CitationTarget: Progesterone Receptors|Glucocorticoid ReceptorsSummary: Progesterone receptor antagonist